Your browser doesn't support javascript.
loading
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
Baliakas, Panagiotis; Moysiadis, Theodoros; Hadzidimitriou, Anastasia; Xochelli, Aliki; Jeromin, Sabine; Agathangelidis, Andreas; Mattsson, Mattias; Sutton, Lesley-Ann; Minga, Eva; Scarfò, Lydia; Rossi, Davide; Davis, Zadie; Villamor, Neus; Parker, Helen; Kotaskova, Jana; Stalika, Evangelia; Plevova, Karla; Mansouri, Larry; Cortese, Diego; Navarro, Alba; Delgado, Julio; Larrayoz, Marta; Young, Emma; Anagnostopoulos, Achilles; Smedby, Karin E; Juliusson, Gunnar; Sheehy, Oonagh; Catherwood, Mark; Strefford, Jonathan C; Stavroyianni, Niki; Belessi, Chrysoula; Pospisilova, Sarka; Oscier, David; Gaidano, Gianluca; Campo, Elias; Haferlach, Claudia; Ghia, Paolo; Rosenquist, Richard; Stamatopoulos, Kostas.
Afiliación
  • Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Moysiadis T; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Hadzidimitriou A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Xochelli A; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Jeromin S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Agathangelidis A; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Mattsson M; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Sutton LA; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Minga E; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Scarfò L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Rossi D; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Davis Z; Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
  • Villamor N; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Parker H; Department of Haematology, Royal Bournemouth Hospital, UK.
  • Kotaskova J; Hemopathology Unit, Hospital Clinic, Barcelona, Spain.
  • Stalika E; Cancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, UK.
  • Plevova K; Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
  • Mansouri L; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Cortese D; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Navarro A; Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
  • Delgado J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Larrayoz M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Young E; Hemopathology Unit, Hospital Clinic, Barcelona, Spain.
  • Anagnostopoulos A; Hematology Department, Hospital Clinic, Barcelona, Spain.
  • Smedby KE; Cancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, UK.
  • Juliusson G; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Sheehy O; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Catherwood M; Department of Medicine, Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden.
  • Strefford JC; Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Sweden.
  • Stavroyianni N; Department of Hemato-Oncology, Belfast City Hospital, UK.
  • Belessi C; Department of Hemato-Oncology, Belfast City Hospital, UK.
  • Pospisilova S; Cancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, UK.
  • Oscier D; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Gaidano G; Hematology Department, Nikea General Hospital, Pireaus, Greece.
  • Campo E; Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
  • Haferlach C; Department of Haematology, Royal Bournemouth Hospital, UK.
  • Ghia P; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Rosenquist R; Hemopathology Unit, Hospital Clinic, Barcelona, Spain.
  • Stamatopoulos K; Department of Pathology, University of Barcelona, Spain.
Haematologica ; 104(2): 360-369, 2019 02.
Article en En | MEDLINE | ID: mdl-30262567
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Biomarcadores de Tumor / Susceptibilidad a Enfermedades Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Biomarcadores de Tumor / Susceptibilidad a Enfermedades Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article País de afiliación: Suecia